Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for prevention of preeclampsia in high-risk pregnant women
IRCT20230730058975N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of metformin in preeclampsia (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: preeclampsia. Started Aug 2023; status: completed.
02
Drugs
metformin
03
Conditions
preeclampsia
Beyond the preview
Go deeper on IRCT20230730058975N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230730058975N1.